soulfeast
Senior Member
- Messages
- 420
- Location
- Virginia, US
Curious how Brewer folks are dealing with bleeding?
The two papers are linked - the first paper is what was used to set the level that the second paper judged clinically significance and which also yielded what passed for the controls in the second paper. It was far from an ideal arrangement, not helped by a change in description in the second paper of the controls to 'healthy' when there was no apparent consistent testing of their health.I see, so you're not talking about Brewer's paper on detection of mycotoxins.
That's certainly true but we know very little about the effects of any kind of environmental element in MECFS, except perhaps that autoimmunity rather immunodeficiency appears the more active process in MECFS.So we know the effects of large exposure, but we don't know the effects of smaller exposures. Specifically, we don't know the effects of smaller exposures on people genetically susceptible to MECFS who may also be undergoing another biological stress.
No, in the sense that the two amounts of 'tiny' are relative - we know the levels of acute toxicity of common mycotoxins, and we know the effects of chronic subacute exposure - organ damage etc, in a range of animals. These levels are greatly above the kind of levels that promote allergic responses in susceptible humans. When I first posted in this thread I made the point that allergic response was a far more probable reaction to mold elements - be they toxic or not - than a toxic response. There are arguments for genetic aspects in susceptibility to poisons - however if that were in play with mycotoxins one would expect susceptible individuals to show exceptional levels of organ disease rather than the amorphous symptomology of MECFS.Wouldn't this be like saying the presence of tiny levels of grass pollen in the air would lead to an allergic reaction in every human if some humans are disabled by them?"
Species of fungus produce distinct mycotoxins - they're simply by-products of the fungus' metabolic processes. There are some toxins that are known to be produced by more than one fungal species but so far the total number of micro fungi species involved seems to be small. Things are different with the fungi that produce large fruiting bodies - mushrooms etc, where a few toxins are found across a large range of species.I suppose it is also possible that the infection produces multiple types of mycotoxin, and the urine tests simply act as a marker, so it could be that small levels of particularly potent mycotoxins are more the problem than the known (eg. aflatoxin) mycotoxins.
I don't know about 'wrong' - I'd say that there isn't a falsifiable hypothesis shown to be robust in the face of adequate scientific rigour. In the case of the second Brewer paper the lack of an in trial control group means that no real conclusions can be made about treatment outcomes - basically where was the placebo ?I am curious as to how you would explain Brewer's results - that reduction of mycotoxins in urine corresponds to symptom improvement? Or perhaps you think he's made a mistake? (sorry if this is repeating earlier discussion )
I think we know quite comprehensibly from Shoemaker's work the effect indoor environmental mold (or mold-associated toxins) has on patients with symptoms identical to those of MECFS.That's certainly true but we know very little about the effects of any kind of environmental element in MECFS, except perhaps that autoimmunity rather immunodeficiency appears the more active process in MECFS.
I used allergy as an analogy, but my general point is that I don't see how you can claim that because some people are made ill by a certain level of a toxin that all people will be made ill by that level.No, in the sense that the two amounts of 'tiny' are relative - we know the levels of acute toxicity of common mycotoxins, and we know the effects of chronic subacute exposure - organ damage etc, in a range of animals. These levels are greatly above the kind of levels that promote allergic responses in susceptible humans.
Shoemaker has already showed the effect of chronic exposure to mold or mold-related toxins is chronic innate immune activation which does indeed give rise to amorphous symptomology rather than exceptional levels of organ disease.There are arguments for genetic aspects in susceptibility to poisons - however if that were in play with mycotoxins one would expect susceptible individuals to show exceptional levels of organ disease rather than the amorphous symptomology of MECFS.
Wouldn't disagree with that- have a look at what this looks like on peanuts - http://services.leatherheadfood.com/eman/FactSheet.aspx?ID=78. That level of mould growth on a human, isn't going to be something you'd miss.
I agree it could be something associated with or interacting with the mold rather than the mycotoxins themselves.If the argument is that the test is for a biomarker for infection- then we return to the problem of excluding environmental confounders where the test sets clinical significance at an exceptionally low level.
Yeah no placebo is a problem, I suppose we will just have to wait.In the case of the second Brewer paper the lack of an in trial control group means that no real conclusions can be made about treatment outcomes - basically where was the placebo ?
I think the physicians treating these patients could recognise an allergy. I don't think the nasal congestion and post-nasal drip respond to anti-histamines.And the whole things seems to avoid confronting the obvious: there are people who belong to the larger ME patient population (in which allergy type symptoms are widely reported), who have symptoms of nasal congestion and facial sinus pain that are A1 typical of allergy. Yet some esotoric explantion involving mystery fungi doing things that fungi haven't been shown to do (i.e produce toxins in vivo without causing either major organ damage or surface tissue damage) is preferred to an explantion of allergy.
Again, the work of Shoemaker is completely at odds with this, it is not an allergic response. The symptoms of MECFS (and those of CIRS) do not correlate with allergy and histamine release, there is no measurable allergic reaction but there is measurable innate activation and downstream consequencies (raised complement, tgf-beta, low VEGF, raised leptin etc etc).I think it is quite telling that there are people who identify mould affected buildings as a source of their ill health, who then get better by changing environments - this is typical of allergy and mystic toxic moulds aren't necessary to explain what has happened.
Sorry, he does not.Does anyone know if Dr. Brewer does phone consults?
Thanks for letting me know! That's too bad.Sorry, he does not.
Yes the BEG spray contains EDTA for breaking down biofilm, but this is for MARCoNS rather than fungal infections. See eg. http://www.survivingmold.com/docs/McMahon_11_Step_Biotoxin_Elimination_Pathway_Essay.pdfInteresting that Dr. Shoemaker apparently treats for biofilms, but uses antibiotics instead of antifungals, at least according to ggingues at the bottom of this page:
http://forums.phoenixrising.me/inde...ling-with-sinus-issues.2086/page-2#post-51646
http://lymebytes.blogspot.co.uk/2011_05_01_archive.htmlAll chronic fatigue patients have two things in common: First, viruses aren't their primary reason for fatigue. Rather, parasites and chronic sinus infections are more likely to be a primary cause.
Chronic, antibiotic-resistant staph, strep and mold infections in the sinuses produce mycotoxins which enter the hypothalamus and affect its function
Allergy can be quite difficult to exclude - http://www.waojournal.org/content/pdf/1939-4551-6-11.pdf . If the Rituximab studies show relevance to ME then allergy as an autoimmune function will need to be factored in to future thinking about the illness - http://www.nih.gov/news/health/jun2013/nci-02.htm and also http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121058/ The fact that antihistamines don't work or are only of limited value doesn't rule out allergy just highlights the limits of current medication.I think the physicians treating these patients could recognise an allergy. I don't think the nasal congestion and post-nasal drip respond to anti-histamines.
Again, the work of Shoemaker is completely at odds with this, it is not an allergic response. The symptoms of MECFS (and those of CIRS) do not correlate with allergy and histamine release, there is no measurable allergic reaction but there is measurable innate activation and downstream consequencies (raised complement, tgf-beta, low VEGF, raised leptin etc etc).
I've no doubt allergy can be difficult to exclude, and no doubt there are links between many immune disorders.Allergy can be quite difficult to exclude - http://www.waojournal.org/content/pdf/1939-4551-6-11.pdf . If the Rituximab studies show relevance to ME then allergy as an autoimmune function will need to be factored in to future thinking about the illness - http://www.nih.gov/news/health/jun2013/nci-02.htm and also http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121058/ The fact that antihistamines don't work or are only of limited value doesn't rule out allergy just highlights the limits of current medication.
Shoemaker doesn't appear to have any peer reviewed published work, let alone replication studies supporting his hypothesis. The Shoemaker approach may look good on paper but really these lone operaters aren't contributing to meanigful research. If patients want to take a physician solley on trust that's their right, but it is not how the science of illness progresses.
Yes the BEG spray contains EDTA for breaking down biofilm, but this is for MARCoNS rather than fungal infections. See eg. http://www.survivingmold.com/docs/McMahon_11_Step_Biotoxin_Elimination_Pathway_Essay.pdf
Brewer does not test for this. Given that the treatment causes mycotoxin levels to drop and health to improve (at least in some patients) it seems unlikely.Playing the devil's advocate here. Is it possible that what is going on in Brewer's patients is that they are effectively indirectly treating MARCONs due to the fact that the spray prescribed contains EDTA? Did Brewer rule out MARCONs (or other biotoxin producing bacteria) in the patients presumably being treated for fungal infections?
I am near the end of my first week. My wife and daughter are near the end of their second week. It has gone the way Brewer said it should go. The first has been worse then the second week not so bad. I would describe it as doable, but not much fun. It is more of everything. More fatigue, more malaise, more body aches, more irritabillity. We all felt worse immediately upon using the Chelating PX. Brewer has tried to tweak the protocol so it is tolerable and you can stay the course. Previously doing the Ampo B twice a day was too overwhelming for patients.
One explanation, of course, would be that CFS patients respond poorly to any medication, but my feeling is that there really is a die off going on. I have sprayed an endless array of medications in my nose over the years, but it never felt anything like this.
Good to hear that you are better. Can you elaborate on what your doctor said about mast cell activation and gastrocrom? My daughter will see Brewer in a few weeks and I want to ask him about mast cell activation.One week in and I feel better. I also started gastrocrom for mast cell activation and it will calm down cytokines. Maybe I need more time into this or we are hitting different bugs and not ones carrying mycos. I am having a lot of bloody mucous, though. Not too bad, but not scanty either.
Good to hear that you are better. Can you elaborate on what your doctor said about mast cell activation and gastrocrom? My daughter will see Brewer in a few weeks and I want to ask him about mast cell activation.
Good to hear that you are better. Can you elaborate on what your doctor said about mast cell activation and gastrocrom? My daughter will see Brewer in a few weeks and I want to ask him about mast cell activation.
Didn't want to say anything when you were feeling better, but I think if the protocol is going to work some suffering is inevitable. It took me eight weeks to turn the corner and now I've been better for five days. On the other hand my daughter is still not better after nine weeks. If she is to fall in the 2 to 12 week range Brewer talked about she'll have to hurry up.I've crashed today.. really tired. Little sleep night before and huge appointment with an EDS specialist that took all day. So not feeling so good today. Don't want it to sound like I think this will be a piece of cake. It was just interesting that my legs for days and soon after starting the sinus protocol and adding in gastrocrom felt better than they have in almost a decade. Today.. they are heavy.